Investments (#)


    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.


    DISCLAIMER: This chart is based on a limited amount of data and may change once additional information has been added. We are working hard to ensure the completeness of the data. If you want to assist us in our work, please contact us using this form.

    Recent transactions in the domain of drug development

    Country Funding round Date
    Metsera Inc
    Developer of medicines for obesity and metabolic diseases.
    United States Series B
    USD 215,000,000 (USD 215,000,000)
    13 Nov 2024
    Abalone Bio
    Antibody drug discovery.
    United States Seed
    31 Dec 2020
    Memo Therapeutics AG
    Switzerland N/A
    Memo Therapeutics AG
    Switzerland N/A
    Memo Therapeutics AG
    Switzerland N/A
    Memo Therapeutics AG
    Switzerland N/A

    Best funded companies in drug development





    Developer of medicines for obesity and metabolic diseases.

    Investment themes:

    Top investors in the domain of drug development

    Profile Country Investments
    T Rowe Price Group Inc Asset management firm. United States 1
    SymBiosis Capital Management Biotech venture capital firm. 1
    Zurich Cantonal Bank Switzerland 1
    Deep Track Capital LP Investment firm focused exclusively on the life sciences industry. United States 1
    Schroder Adveq Management AG 1
    ARCH Venture Partners LP Venture capital firm providing seed and early stage capital, with a special expertise in co-founding and building technology firms from startup United States 1
    Venrock Associates The venture capital arm of the Rockefeller Family. United States 1
    GV. The venture capital arm of Alphabet Inc. (Formerly Google Ventures.) United States 1
    Janus Henderson Group PLC Global asset management group. United Kingdom 1
    Newpath Partners LP United States 1
    Verve Capital Partners AG Switzerland 1
    Viking Global Investors LP 1
    Redalpine Venture Partners AG Seed and early-stage venture capital firm investing in disruptive technologies with focus on highly scalable ICT and Health Tech models. Switzerland 1
    RA Capital Management 1
    Wellington Management Co LLP Investment management firm headquartered in Boston, Massachussets. United States 1
    Alpha Wave Global LP 1
    Fidelity Management and Research Co investment management firm offering mutual funds, brokerage, retirement solutions, and asset management for institutions. 1
    Y Combinator American technology startup accelerator. United States 1
    Softbank Capital Partners Early stage venture capital firm United States 1

    drug development industry map

    immunology

    See all immunology
    drug discovery
    inflammatory diseases
    antibody development
    YCW20

    See all YCW20
    healthcare

    See all healthcare
    antibody drugs
    psychodelic drugs
    psychodelic medicines
    psychodelic therapies